Role of bone marrow transplantation for correcting hemophilia A in mice
- 7 June 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 119 (23), 5532-5542
- https://doi.org/10.1182/blood-2011-07-367680
Abstract
To better understand cellular basis of hemophilia, cell types capable of producing FVIII need to be identified. We determined whether bone marrow (BM)–derived cells would produce cells capable of synthesizing and releasing FVIII by transplanting healthy mouse BM into hemophilia A mice. To track donor-derived cells, we used genetic reporters. Use of multiple coagulation assays demonstrated whether FVIII produced by discrete cell populations would correct hemophilia A. We found that animals receiving healthy BM cells survived bleeding challenge with correction of hemophilia, although donor BM-derived hepatocytes or endothelial cells were extremely rare, and these cells did not account for therapeutic benefits. By contrast, donor BM-derived mononuclear and mesenchymal stromal cells were more abundant and expressed FVIII mRNA as well as FVIII protein. Moreover, injection of healthy mouse Kupffer cells (liver macrophage/mononuclear cells), which predominantly originate from BM, or of healthy BM-derived mesenchymal stromal cells, protected hemophilia A mice from bleeding challenge with appearance of FVIII in blood. Therefore, BM transplantation corrected hemophilia A through donor-derived mononuclear cells and mesenchymal stromal cells. These insights into FVIII synthesis and production in alternative cell types will advance studies of pathophysiological mechanisms and therapeutic development in hemophilia A.Keywords
This publication has 50 references indexed in Scilit:
- In vivo efficacy of platelet-delivered, high specific activity factor VIII variantsBlood, 2010
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: Is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory SitesScience, 2009
- Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunctionCardiovascular Research, 2009
- Directed Engineering of a High-expression Chimeric Transgene as a Strategy for Gene Therapy of Hemophilia AMolecular Therapy, 2009
- The haemangioblast generates haematopoietic cells through a haemogenic endothelium stageNature, 2009
- Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunityBlood, 2008
- Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A miceJCI Insight, 2008
- Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantationProceedings of the National Academy of Sciences of the United States of America, 2006